Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Oxybutynin Chloride 1 mg/ml Oral Syrup (Gluten Free/Flavored)

FDA-approved generic
Dose form
Oral Syrup
Active ingredients
Oxybutynin Chloride
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Oxybutynin Chloride
Oral Syrup
6427079ea643245494518f93
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded oral syrup containing oxybutynin chloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing oxybutynin are listed in syrup, tablet, patch and solution forms.

Storage category and dating

This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Oxybutynin is an antimuscarinic bladder antispasmodic that compounding pharmacies prepare by prescription in oral, intravesical and other forms.

About this ingredient

Oxybutynin chloride is an anticholinergic, antimuscarinic drug. It blocks acetylcholine at muscarinic receptors on bladder smooth muscle and has a direct antispasmodic effect, which relaxes the bladder. Oxybutynin chloride tablets (for example Teva) are FDA-approved for symptoms of bladder instability in uninhibited or reflex neurogenic bladder, such as urgency, frequency, leakage and urge incontinence. Extended-release tablets are approved for overactive bladder and for children 6 years and older with detrusor overactivity from a neurological condition such as spina bifida, and the Oxytrol patch is approved for overactive bladder in men, with a version for women sold over the counter. A syrup is also manufactured. A prescriber may order oxybutynin compounded when a patient needs a strength or dosage form that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

Oxybutynin has no boxed warning. Do not take it if you have urinary retention, gastric retention or other severe slowing of the gut, uncontrolled narrow-angle glaucoma, or an allergy to it. Swelling of the face, lips, tongue or throat (angioedema) has been reported, sometimes after the first dose; get emergency help if it happens. It can cause confusion, hallucinations, agitation and drowsiness, especially in the first months or after a dose increase, and it can make it harder for your body to cool down in hot weather. Other anticholinergic drugs add to dry mouth, constipation and drowsiness, and ketoconazole and other CYP3A4 inhibitors can raise its levels. Safety in pregnancy has not been established. LactMed has no breastfeeding data and notes that long-term use might reduce milk production. Talk to your prescriber or pharmacist about side effects.

Oxybutynin competitively blocks M1, M2 and M3 muscarinic receptors (StatPearls) and has a direct antispasmodic effect; on rabbit detrusor it showed one fifth the anticholinergic activity of atropine but four to ten times the antispasmodic activity (Teva label). After oral tablets, peak levels occur within an hour, absolute bioavailability is about 6% (range 1.6% to 10.9%), and plasma levels fall with a half-life of about 2 to 3 hours. Volume of distribution is 193 L and protein binding exceeds 99%, mainly to alpha-1 acid glycoprotein. CYP3A4 in the liver and gut wall forms the active metabolite desethyloxybutynin, and under 0.1% is excreted unchanged; ketoconazole raised levels 3 to 4 fold. Labeled indications: tablets for neurogenic bladder symptoms; extended-release tablets for overactive bladder and pediatric neurogenic detrusor overactivity; Oxytrol for overactive bladder in men. StatPearls describes intravesical instillation and rectal suppository use, and off-label use for primary focal hyperhidrosis and catheter or stent-related bladder spasm. Dosing is per prescriber. Monitor anticholinergic CNS effects, urinary retention, heat intolerance and angioedema; StatPearls advises caution in older adults and in dementia treated with cholinesterase inhibitors. Oxybutynin is not a controlled substance.

Sources

Using and storing

How it is used

Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup provided, not a household spoon. Take it by mouth as directed on the label. Rinse the measuring device and recap the bottle after each dose.

Storing it

Syrups are aqueous preparations. Under USP <795>, a preserved syrup usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Your label shows whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Oxybutynin Chloride 1 mg/ml Oral Syrup (Gluten Free/Flavored)
Oral Syrup
controlled

Take orally

5-10 mg (1 ml) every 6-8 hours for children aged 3-5 years; 10-15 mg (2 ml) every 6-8 hours for children aged 6-12 years; and 15-30 mg (3-6 ml) every 8-12 hours for adults.
Every 6 to 8 hours